US Bancorp
- SEC CIK
- 0000036104
- Latest filing
- Aug 12, 2026
INBX holding history
Inhibrx Biosciences, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
INBX overviewAll 13F holders of INBXFull Q2 2026 holdings
- Shares (Q2 2026)
- 62
- Value
- $5.88K
- % of portfolio
- <0.1%
- Quarters held
- 15
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 62 | $5.88K | <0.1% | −157−71.7% | Reduced | Holders |
| Q1 2026 | 219 | $14.7K | <0.1% | +16+7.9% | Added | Holders |
| Q4 2025 | 203 | $16.0K | <0.1% | −14−6.5% | Reduced | Holders |
| Q3 2025 | 217 | $7.31K | <0.1% | +217 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −16−100.0% | Sold out | Holders |
| Q1 2025 | 16 | $224 | <0.1% | −107−87.0% | Reduced | Holders |
| Q4 2024 | 123 | $1.89K | <0.1% | −2,175−94.6% | Reduced | Holders |
| Q3 2024 | 2,298 | $36.0K | <0.1% | +2,175+1,768.3% | Added | Holders |
| Q2 2024 | 123 | $1.74K | <0.1% | −373−75.2% | Reduced | Holders |
| Q1 2024 | 496 | $17.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 496 | $18.8K | <0.1% | +303+157.0% | Added | Holders |
| Q3 2023 | 193 | $3.54K | <0.1% | +128+196.9% | Added | Holders |
| Q2 2023 | 65 | $1.69K | <0.1% | +65 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −123−100.0% | Sold out | Holders |
| Q3 2022 | 123 | $2.00K | <0.1% | −19−13.4% | Reduced | Holders |
| Q2 2022 | 142 | $2.00K | <0.1% | +142 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −12−100.0% | Sold out | Holders |
| Q4 2021 | 12 | $1.00K | <0.1% | +12 | New | Holders |